13 studies found for:    Gd-DOTA
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Conditions: Diagnostic Self Evaluation;   Central Nervous System Diseases
Interventions: Drug: Dotarem (gadoterate meglumine);   Drug: Magnevist (gadopentetate dimeglumine)
2 Completed
Has Results
Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease
Condition: Peripheral Arterial Disease
Interventions: Drug: Dotarem;   Drug: Gadovist
3 Recruiting DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
Condition: Hepatocellular Carcinoma
Intervention: Drug: Meglumine Gadoterate
4 Recruiting Crossover Comparison of MultiHance and Dotarem
Condition: Brain Disease
Interventions: Drug: Gadobenate;   Drug: Gadoterate
5 Terminated
Has Results
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Condition: Renal Artery Stenosis
Interventions: Drug: Gadoterate meglumine (Dotarem);   Other: Time of Flight Magnetic Resonance Angiography
6 Completed Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.
Condition: Neoplastic CNS Lesions
Interventions: Drug: Gadovist® (Gadobutrol, BAY86-4875);   Drug: Dotarem
7 Completed Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Condition: Carotid or Vertebral Arterial Disease
Interventions: Drug: Dotarem;   Other: TOF MRA
8 Completed Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Conditions: Carotid Arterial Disease;   Vertebral Arterial Disease
Interventions: Drug: Dotarem;   Other: TOF MRA
9 Recruiting Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
Condition: Primary Brain Tumor
Interventions: Drug: Dotarem®;   Drug: Gadovist®/Gadavist®
10 Completed
Has Results
DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases
Condition: Peripheral Arterial Disease
Intervention: Other: Contrast-enhanced MRA - Imaging examination
11 Completed Renal Safety Evaluation After Dotarem-enhanced MRI
Condition: Nephropathy
Interventions: Drug: Dotarem;   Procedure: non-enhanced MRI
12 Completed Safety and Dialysability of Dotarem® in Dialysed Patients
Condition: End-stage Renal Failure
Intervention: Drug: Dotarem
13 Terminated Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)
Condition: Renal Arterial Disease
Intervention: Drug: Dotarem

Indicates status has not been verified in more than two years